[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.142.219. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Viewpoint
ONLINE FIRST
June 26, 2013

Sorting Through the Arguments on Breast Screening

Author Affiliations

Author Affiliation: Department of Epidemiology and Public Health, Institute of Health Equity at University College, London, England.

JAMA. 2013;309(24):2553-2554. doi:10.1001/jama.2013.6822

Views on the benefits and harms of breast cancer screening are sharply polarized and increasingly vocal. Allegations of harming women are flung in both directions. The antiscreeners claim that benefit is minimal and overdiagnosis is so frequent that women are being subject to unnecessary interventions and treatment. The proscreeners claim that if the critics win the day, women will be deprived of the benefits that screening brings of early diagnosis and reductions in mortality from breast cancer.

First Page Preview View Large
First page PDF preview
First page PDF preview
×